Igenica, Inc. To Present New Data At The World ADC Summit
Published: Feb 13, 2014
BURLINGAME, Calif.--(BUSINESS WIRE)--Igenica, Inc., a company focused on the discovery and development of innovative antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that it will present insights into its proteomic target discovery platform and ADC technology during a plenary session of the World ADC meeting, being held February 17-20 in Frankfurt, Germany.
Help employers find you! Check out all the jobs and post your resume.